Business Context and Reporting Period
This Form 8-K Current Report was filed by Phibro Animal Health Corporation on July 30, 2024. The filing primarily addresses a corporate action regarding shareholder distributions rather than reporting on a specific fiscal period's operational results.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics. The only specific financial data disclosed is:
- Dividend Declaration: $0.12 per share.
- Applicable Shares: Class A Common Stock and Class B Common Stock.
- Record Date: September 4, 2024.
- Payment Date: September 25, 2024.
Material Changes
The material event reported is the declaration of a quarterly cash dividend. No material changes to revenue, operating margins, or debt levels are disclosed in this specific filing.
Guidance, Outlook, and Risks
This filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It strictly reports the dividend declaration as an "Other Event" under Item 8.01.
Investor Verification Checklist
- Verify the Record Date (September 4, 2024) to ensure eligibility for the dividend.
- Confirm the Payment Date (September 25, 2024) for cash flow planning.
- Review the attached Exhibit 99.1 (Press Release) for any additional context not included in the 8-K summary.
- Note that this filing does not contain updated financial performance data; refer to the most recent 10-Q or 10-K for operational metrics.